Abbott Laboratories Retained Earnings (Accumulated Deficit) 2010-2024 | ABT

Abbott Laboratories retained earnings (accumulated deficit) for the quarter ending December 31, 2024 were $47.261B, a 25.85% increase year-over-year.

  • Abbott Laboratories retained earnings (accumulated deficit) for 2024 were $47.261B, a 25.85% increase from 2023.
  • Abbott Laboratories retained earnings (accumulated deficit) for 2023 were $37.554B, a 6.52% increase from 2022.
  • Abbott Laboratories retained earnings (accumulated deficit) for 2022 were $35.257B, a 11.83% increase from 2021.

Abbott Laboratories Retained Earnings (Accumulated Deficit) 2010-2024 | ABT

  • Abbott Laboratories retained earnings (accumulated deficit) for 2024 were $47.261B, a 25.85% increase from 2023.
  • Abbott Laboratories retained earnings (accumulated deficit) for 2023 were $37.554B, a 6.52% increase from 2022.
  • Abbott Laboratories retained earnings (accumulated deficit) for 2022 were $35.257B, a 11.83% increase from 2021.